These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 2756462

  • 21. Second-look laparotomy in stage I ovarian cancer following comprehensive surgical staging.
    Rubin SC, Jones WB, Curtin JP, Barakat RR, Hakes TB, Hoskins WJ.
    Obstet Gynecol; 1993 Jul; 82(1):139-42. PubMed ID: 8515914
    [Abstract] [Full Text] [Related]

  • 22. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.
    Forum (Genova); 2000 Jul; 10(4):323-32. PubMed ID: 11535983
    [Abstract] [Full Text] [Related]

  • 23. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T, Klasa-Mazurkiewicz D, Emerich J, Kobierski J.
    Acta Obstet Gynecol Scand; 2009 Jul; 88(4):463-7. PubMed ID: 19235559
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A, Iacconi P, Fanucchi A, Cosio S, Teti G, Genazzani AR.
    Anticancer Res; 2000 Jul; 20(3B):1959-64. PubMed ID: 10928134
    [Abstract] [Full Text] [Related]

  • 29. Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging.
    Rubin SC, Wong GY, Curtin JP, Barakat RR, Hakes TB, Hoskins WJ.
    Obstet Gynecol; 1993 Jul; 82(1):143-7. PubMed ID: 8515915
    [Abstract] [Full Text] [Related]

  • 30. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
    Culine S, Lhomme C, Michel G, Leclere J, Duvillard P, Droz JP.
    J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
    [Abstract] [Full Text] [Related]

  • 31. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
    Spirtos NM, Eisenkop SM, Schlaerth JB, Ballon SC.
    Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
    [Abstract] [Full Text] [Related]

  • 32. [Expectations and defeat in the treatment of epithelial cancer of the ovary].
    Weil M, Borel C, Auclerc G, Forget G, Durandin-Truffinet M, Thill L, Khayat D, Jacquillat C.
    Ann Med Interne (Paris); 1990 Jun; 141(1):15-9. PubMed ID: 2321883
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.
    Friedman RL, Eisenkop SM, Wang HJ.
    Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362
    [Abstract] [Full Text] [Related]

  • 35. [Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].
    Israël L, Lepage E, Breau JL, Aguilera J.
    Bull Cancer; 1982 Oct; 69(5):426-33. PubMed ID: 6891902
    [Abstract] [Full Text] [Related]

  • 36. Retrospective cohort study of surgical staging for ovarian low malignant potential tumors.
    Wingo SN, Knowles LM, Carrick KS, Miller DS, Schorge JO.
    Am J Obstet Gynecol; 2006 May; 194(5):e20-2. PubMed ID: 16647891
    [Abstract] [Full Text] [Related]

  • 37. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
    Bertucci F, Viens P, Delpero JR, Bardou VJ, Faucher C, Houvenaeghel G, Maraninchi D.
    Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
    [Abstract] [Full Text] [Related]

  • 38. [Treatment of advanced ovarian cancer].
    de Gramont A, Krulik M, Pigne A, Brissaud P, Sirinelli A, Hubert D, Zylberait D, Debray J.
    Sem Hop; 1984 Mar 29; 60(14):957-60. PubMed ID: 6326283
    [Abstract] [Full Text] [Related]

  • 39. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T, Velten M, d'Hombres A, Marchal C, Montbarbon X, Mornex F, Quetin P, Gérard JP, Romestaing P, Carrie C.
    Gynecol Oncol; 2007 Jan 29; 104(1):104-8. PubMed ID: 16987544
    [Abstract] [Full Text] [Related]

  • 40. Tumors of low malignant potential.
    Leake JF.
    Curr Opin Obstet Gynecol; 1992 Feb 29; 4(1):81-5. PubMed ID: 1543834
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.